Synthego's Series B - II Round

Synthego raised a round of funding on October 19, 2017. Investors include Intel Capital.

Synthego is a provider of genome engineering solutions. The company's flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. Synthego's vis…

Articles about Synthego's Series B - II Round: